Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Illumina, Inc. (ILMN) – Illumina, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Illumina (ILMN) trades at $126.74, down 0.14% on the day, with a bearish technical signal but recent earnings beats. The company shows strong profitability margins (gross margin 66.08%, net margin 19.57%) and a return to positive net income in 2025 after losses in prior years. Cash flow improved to $291M net in 2025, and debt-to-asset ratio declined to 29.93%. Recent news highlights product launches like DRAGEN v4.5 and partnerships for pediatric cancer research.
Outlook is mixed: analyst consensus is a Buy with a $145 price target (17% upside), but technicals are bearish and competition from Roche poses risks. Earnings growth and operational efficiency improvements are key catalysts, though high valuation multiples (P/E 22.09, P/B 6.72) and debt levels warrant caution. The stock offers potential for recovery if execution continues to beat expectations.
Read full analysis

Key Stats

  • Market Cap
    $18.29B
  • Sector
    Health
  • 3M Drawdown
    -18.91%
  • Enterprise Value
    $19.21B
  • Dividend Yield
    -
  • Typical Hold Time
    87 days
$126.35
52W Low: $74.53
06 May 2025
52W High: $153.95
22 Jan 2026

Illumina, Inc. (ILMN) is currently valued at a market capitalization of $18.29B, with an enterprise value of $19.21B. Over the past 52 weeks, Illumina, Inc. has traded between a low of $74.53 and a high of $153.95, highlighting its annual price range. Over the past three months, Illumina, Inc. has recorded a drawdown of -18.91%, reflecting recent price volatility. On average, investors hold Illumina, Inc. for approximately 87 days, indicating typical investor behavior on the platform.

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.


Technical Indicators
|
|
|
Overall Summary
Bearish (2)Neutral (8)Bullish (17)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $18.29B
  • Sector
    Health
  • 3M Drawdown
    -18.91%
  • Enterprise Value
    $19.21B
  • Dividend Yield
    -
  • Typical Hold Time
    87 days
$126.35
52W Low: $74.53
06 May 2025
52W High: $153.95
22 Jan 2026

Illumina, Inc. (ILMN) is currently valued at a market capitalization of $18.29B, with an enterprise value of $19.21B. Over the past 52 weeks, Illumina, Inc. has traded between a low of $74.53 and a high of $153.95, highlighting its annual price range. Over the past three months, Illumina, Inc. has recorded a drawdown of -18.91%, reflecting recent price volatility. On average, investors hold Illumina, Inc. for approximately 87 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!